Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antitumor activity and molecular mechanism of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition
Huimin Sun, Wen Meng, Jie Zhu, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 6, pp. 643-658
Closed Access | Times Cited: 10

Showing 10 citing articles:

PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages
Lu Wang, Shuangshuang Li, Huanhua Luo, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 140
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond
Nabil G. Seidah, Damien Garçon
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 10, pp. 821-830
Open Access | Times Cited: 55
Cholesterol metabolism in tumor microenvironment: cancer hallmarks and therapeutic opportunities
Wen G. Jiang, Weilin Jin, Aman Xu
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2044-2071
Open Access | Times Cited: 9
The evolving landscape of PCSK9 inhibition in cancer
Palak P. Oza, Khosrow Kashfi
European Journal of Pharmacology (2023) Vol. 949, pp. 175721-175721
Open Access | Times Cited: 22
PCSK9 in T-cell function and the immune response
Yuying Wang, Xiaosheng Fang, Jiarui Liu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Ezetimibe mediated RPS6KA2 inhibits colorectal cancer proliferation via PCSK9/MAPK signaling pathway
Yu Wang, Yuting Wang, Huabin Gao, et al.
Cancer Treatment and Research Communications (2025), pp. 100899-100899
Open Access
Construction of an endoplasmic reticulum stress-related signature in lung adenocarcinoma by comprehensive bioinformatics analysis
Yang Wang, Jun Nie, Ling Dai, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study
Lusheng Miao, Taosheng Miao, Ying Zhang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Development of a prognostic model for lung adenocarcinoma polarity‐related genes and analysis of immune landscape
Hongqiu Xu, Wenqiang Du, Xuelong Jing, et al.
Biotechnology and Applied Biochemistry (2024) Vol. 71, Iss. 4, pp. 817-834
Closed Access
Cholesterol Metabolism-Mediated Immune Regulation and Cancer Immunotherapy
Jiayu Zhang, Xinting Zhu, Leng Han, et al.
(2024)
Closed Access
Page 1

Scroll to top